C-CAR168
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for C-CAR168, covering 2025-07-25 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy [Phase 1]